BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis

NYSE:BLDR • US12008R1077

95.75 USD
-3.66 (-3.68%)
Last: Mar 3, 2026, 10:06 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

BLDR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Building Products industry. BLDR has only an average score on both its financial health and profitability. BLDR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year BLDR was profitable.
  • In the past year BLDR had a positive cash flow from operations.
  • BLDR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BLDR had a positive operating cash flow.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • BLDR has a Return On Assets (3.87%) which is comparable to the rest of the industry.
  • The Return On Equity of BLDR (10.00%) is comparable to the rest of the industry.
  • BLDR's Return On Invested Capital of 6.62% is on the low side compared to the rest of the industry. BLDR is outperformed by 61.90% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLDR is above the industry average of 11.86%.
  • The 3 year average ROIC (13.95%) for BLDR is well above the current ROIC(6.62%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROIC 6.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • BLDR has a Profit Margin (2.86%) which is comparable to the rest of the industry.
  • BLDR's Profit Margin has declined in the last couple of years.
  • BLDR's Operating Margin of 5.18% is on the low side compared to the rest of the industry. BLDR is outperformed by 76.19% of its industry peers.
  • BLDR's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 30.39%, BLDR is in line with its industry, outperforming 52.38% of the companies in the same industry.
  • BLDR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • BLDR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, BLDR has less shares outstanding
  • Compared to 5 years ago, BLDR has less shares outstanding
  • Compared to 1 year ago, BLDR has a worse debt to assets ratio.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.70 indicates that BLDR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • BLDR has a Altman-Z score of 2.70. This is comparable to the rest of the industry: BLDR outperforms 40.48% of its industry peers.
  • The Debt to FCF ratio of BLDR is 5.21, which is a neutral value as it means it would take BLDR, 5.21 years of fcf income to pay off all of its debts.
  • BLDR has a Debt to FCF ratio (5.21) which is comparable to the rest of the industry.
  • BLDR has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.02, BLDR is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Altman-Z 2.7
ROIC/WACC0.73
WACC9.04%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • BLDR has a Current Ratio of 1.86. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BLDR (1.86) is comparable to the rest of the industry.
  • A Quick Ratio of 1.16 indicates that BLDR should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.16, BLDR is in line with its industry, outperforming 54.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.16
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for BLDR have decreased strongly by -40.24% in the last year.
  • The Earnings Per Share has been growing by 17.40% on average over the past years. This is quite good.
  • BLDR shows a decrease in Revenue. In the last year, the revenue decreased by -7.38%.
  • BLDR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.16% yearly.
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.16% on average over the next years. This is quite good.
  • BLDR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.01% yearly.
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.90, which indicates a correct valuation of BLDR.
  • Compared to the rest of the industry, the Price/Earnings ratio of BLDR indicates a somewhat cheap valuation: BLDR is cheaper than 78.57% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.13, BLDR is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 15.66, the valuation of BLDR can be described as correct.
  • BLDR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BLDR is cheaper than 73.81% of the companies in the same industry.
  • BLDR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.9
Fwd PE 15.66
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLDR indicates a somewhat cheap valuation: BLDR is cheaper than 66.67% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BLDR is valued cheaper than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.41
EV/EBITDA 11.07
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • BLDR's earnings are expected to grow with 14.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.8
EPS Next 2Y7.34%
EPS Next 3Y14.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BLDR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (3/3/2026, 10:06:04 AM)

95.75

-3.66 (-3.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners104.69%
Inst Owner Change-5.29%
Ins Owners2.49%
Ins Owner Change0.08%
Market Cap10.59B
Revenue(TTM)15.19B
Net Income(TTM)435.20M
Analysts71.33
Price Target131.26 (37.09%)
Short Float %4.37%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.45%
Min EPS beat(2)-11.6%
Max EPS beat(2)12.49%
EPS beat(4)3
Avg EPS beat(4)3.94%
Min EPS beat(4)-11.6%
Max EPS beat(4)12.49%
EPS beat(8)7
Avg EPS beat(8)6.47%
EPS beat(12)11
Avg EPS beat(12)20.34%
EPS beat(16)15
Avg EPS beat(16)32.8%
Revenue beat(2)1
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-4.82%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-2.35%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-4.56%
Revenue beat(12)4
Avg Revenue beat(12)-2.6%
Revenue beat(16)8
Avg Revenue beat(16)1.22%
PT rev (1m)-2.06%
PT rev (3m)-4.93%
EPS NQ rev (1m)-50.46%
EPS NQ rev (3m)-54.66%
EPS NY rev (1m)-2.99%
EPS NY rev (3m)-7.88%
Revenue NQ rev (1m)-4.69%
Revenue NQ rev (3m)-6.02%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 13.9
Fwd PE 15.66
P/S 0.7
P/FCF 12.41
P/OCF 8.71
P/B 2.43
P/tB N/A
EV/EBITDA 11.07
EPS(TTM)6.89
EY7.2%
EPS(NY)6.11
Fwd EY6.39%
FCF(TTM)7.72
FCFY8.06%
OCF(TTM)11
OCFY11.48%
SpS137.37
BVpS39.36
TBVpS-8.76
PEG (NY)N/A
PEG (5Y)0.8
Graham Number78.11
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROCE 8.14%
ROIC 6.62%
ROICexc 6.75%
ROICexgc 15.37%
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
FCFM 5.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
ROICexc(3y)14.13%
ROICexc(5y)20.13%
ROICexgc(3y)32.17%
ROICexgc(5y)46.7%
ROCE(3y)17.15%
ROCE(5y)24.51%
ROICexgc growth 3Y-43.15%
ROICexgc growth 5Y-9.26%
ROICexc growth 3Y-42.43%
ROICexc growth 5Y-16.42%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
F-Score5
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Debt/EBITDA 3.21
Cap/Depr 61.31%
Cap/Sales 2.39%
Interest Coverage 3.02
Cash Conversion 88.24%
Profit Quality 196.07%
Current Ratio 1.86
Quick Ratio 1.16
Altman-Z 2.7
F-Score5
WACC9.04%
ROIC/WACC0.73
Cap/Depr(3y)71.45%
Cap/Depr(5y)64.89%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.03%
Profit Quality(3y)151.11%
Profit Quality(5y)131.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A
EBIT growth 1Y-50.7%
EBIT growth 3Y-40.7%
EBIT growth 5Y7.65%
EBIT Next Year35.74%
EBIT Next 3Y19.17%
EBIT Next 5YN/A
FCF growth 1Y-42.81%
FCF growth 3Y-36.03%
FCF growth 5Y41.96%
OCF growth 1Y-35.07%
OCF growth 3Y-30.35%
OCF growth 5Y36.13%

BUILDERS FIRSTSOURCE INC / BLDR FAQ

Can you provide the ChartMill fundamental rating for BUILDERS FIRSTSOURCE INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDR.


What is the valuation status of BUILDERS FIRSTSOURCE INC (BLDR) stock?

ChartMill assigns a valuation rating of 5 / 10 to BUILDERS FIRSTSOURCE INC (BLDR). This can be considered as Fairly Valued.


Can you provide the profitability details for BUILDERS FIRSTSOURCE INC?

BUILDERS FIRSTSOURCE INC (BLDR) has a profitability rating of 5 / 10.


Can you provide the financial health for BLDR stock?

The financial health rating of BUILDERS FIRSTSOURCE INC (BLDR) is 4 / 10.


What is the earnings growth outlook for BUILDERS FIRSTSOURCE INC?

The Earnings per Share (EPS) of BUILDERS FIRSTSOURCE INC (BLDR) is expected to decline by -11.26% in the next year.